Biblio

Found 56 results
Author [ Keyword(Desc)] Title Type Year
Filters: Keyword is Genetic Predisposition to Disease  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Genetic Predisposition to Disease
Naj AC, Jun G, Beecham GW, San Wang L-, Vardarajan BNarayan, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK et al..  2011.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.. Nat Genet. 43(5):436-41.
Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J-C, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JSingh, Moskvina V et al..  2011.  Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.. Nat Genet. 43(5):429-35.
Patel A, Rees SD, M Kelly A, Bain SC, Barnett AH, Prasher A, Arshad H, Prasher VP.  2014.  Genetic variants conferring susceptibility to Alzheimer's disease in the general population; do they also predispose to dementia in Down's syndrome.. BMC Res Notes. 7:42.
Ebbert MTW, Boehme KL, Wadsworth ME, Staley LA, Mukherjee S, Crane PK, Ridge PG, Kauwe JSK.  2016.  Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.. Alzheimers Dement. 12(2):121-129.
Karch CM, Ezerskiy LA, Bertelsen S, Goate AM.  2016.  Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.. PLoS One. 11(2):e0148717.
Kunkle BW, Jaworski J, Barral S, Vardarajan B, Beecham GW, Martin ER, Cantwell LS, Partch A, Bird TD, Raskind WH et al..  2016.  Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.. Alzheimers Dement. 12(1):2-10.
Mez J, Mukherjee S, Thornton T, Fardo DW, Trittschuh E, Sutti S, Sherva R, Kauwe JS, Naj AC, Beecham GW et al..  2016.  The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable.. Neurobiol Aging. 41:115-121.
Sims R, Williams J.  2016.  Defining the Genetic Architecture of Alzheimer's Disease: Where Next.. Neurodegener Dis. 16(1-2):6-11.
Chen JA, Wang Q, Davis-Turak J, Li Y, Karydas AM, Hsu SC, Sears RL, Chatzopoulou D, Huang AY, Wojta KJ et al..  2015.  A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy.. JAMA Neurol. 72(4):414-22.
Malik M, Chiles J, Xi HS, Medway C, Simpson J, Potluri S, Howard D, Liang Y, Paumi CM, Mukherjee S et al..  2015.  Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia.. Hum Mol Genet. 24(12):3557-70.
Reitz C.  2015.  Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities.. Expert Rev Mol Diagn. 15(3):339-48.
Rosenthal E, Blue E, Jarvik GP.  2015.  Next-generation gene discovery for variants of large impact on lipid traits.. Curr Opin Lipidol. 26(2):114-9.
Guerreiro R, Brás J, Hardy J, Singleton A.  2014.  Next generation sequencing techniques in neurological diseases: redefining clinical and molecular associations.. Hum Mol Genet. 23(R1):R47-53.
Karch CM, Cruchaga C, Goate AM.  2014.  Alzheimer's disease genetics: from the bench to the clinic.. Neuron. 83(1):11-26.
Reitz C, Tosto G, Vardarajan B, Rogaeva E, Ghani M, Rogers RS, Conrad C, Haines JL, Pericak-Vance MA, Fallin MD et al..  2013.  Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP).. Transl Psychiatry. 3:e256.
Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BNarayan, San Wang L-, Valladares O, Lin C-F, Larson EB, Graff-Radford NR et al..  2013.  Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans.. JAMA. 309(14):1483-92.
Ridge PG, Mukherjee S, Crane PK, Kauwe JSK.  2013.  Alzheimer's disease: analyzing the missing heritability.. PLoS One. 8(11):e79771.
Thambisetty M, An Y, Tanaka T.  2013.  Alzheimer's disease risk genes and the age-at-onset phenotype.. Neurobiol Aging. 34(11):2696.e1-5.
Cruchaga C, Karch CM, Jin SChih, Benitez BA, Cai Y, Guerreiro R, Harari O, Norton J, Budde J, Bertelsen S et al..  2014.  Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.. Nature. 505(7484):550-554.
Zou F, Chai HSeng, Younkin CS, Allen M, Crook J, V Pankratz S, Carrasquillo MM, Rowley CN, Nair AA, Middha S et al..  2012.  Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.. PLoS Genet. 8(6):e1002707.
Lee JH, Mayeux R, Mayo D, Mo J, Santana V, Williamson J, Flaquer A, Ciappa A, Rondon H, Estevez P et al..  2004.  Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.. Mol Psychiatry. 9(11):1042-51.
Kamboh MI, Barmada MM, Demirci FY, Minster RL, Carrasquillo MM, Pankratz VS, Younkin SG, Saykin AJ, Sweet RA, Feingold E et al..  2012.  Genome-wide association analysis of age-at-onset in Alzheimer's disease.. Mol Psychiatry. 17(12):1340-6.
Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YSon, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, San Wang L- et al..  2014.  Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.. JAMA Neurol. 71(11):1394-404.
Höglinger GU, Melhem NM, Dickson DW, Sleiman PMA, San Wang L-, Klei L, Rademakers R, de Silva R, Litvan I, Riley DE et al..  2011.  Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.. Nat Genet. 43(7):699-705.
Carrasquillo MM, Zou F, V Pankratz S, Wilcox SL, Ma L, Walker LP, Younkin SG, Younkin CS, Younkin LH, Bisceglio GD et al..  2009.  Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.. Nat Genet. 41(2):192-8.